JSB Market Research:Innovation and Clinical Trial Tracking

Views:
 
     
 

Presentation Description

“Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline” is a comprehensive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications. This pipeline is also benchmarked against its size across each segment compared to 2015 and 2016, and an assessment of the level of first-in-class innovation is provided.

Comments

Presentation Transcript

Slide1:

WE ARE JSB Market Research JSB Market Research Pvt . Ltd was formed in 2013 and the portal www.jsbmarketresearch.com for quality primary market research reports was launched to dedicatedly provide quick search service to global clients with no restriction to any industry verticals.

Slide2:

About Report  “Innovation and Clinical Trial Tracking Fact book 2017: An Assessment of the Pharmaceutical Pipeline” is a comprehensive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications.

Slide3:

Tabl e of Content Introduction. Assessment of the Pharmaceutical Industry Pipeline. Assessment of Innovation in the Pharmaceutical Industry Pipeline. Assessment of the Pharmaceutical Industry Clinical Trial Landscape. Appendix.

Slide4:

  Key Reasons to Purchase up-to-date understanding of the landscape of the overall pharmaceutical pipeline. Highly accessible reference which is useful in any pharmaceutical strategic decision making process. Benchmark key therapy areas and indications in terms of the number of pipeline products and level of innovation

Slide5:

Summary “ Innovation and Clinical Trial Tracking Fact book 2017: An Assessment of the Pharmaceutical Pipeline” is a comprehensive, granular analysis of the 25,522 products currently in the pharmaceutical industry pipeline, from the Discovery stage through to Pre-registration and split into therapy areas and key indications

Slide6:

  Scope  What is the current size and composition of the pharmaceutical industry pipeline and how has it changed in the last two years? What can we learn from this?  - The largest therapy area, by a substantial margin, is oncology, and, with growth in the pipeline sizes for all major oncology indications since Q1 2015, this trend appears set to continue. Why is this the case?

Slide7:

Focus Of Report A particular focus of this report is placed on analysis of the development of innovative drugs, specifically first-in-class innovation. The proportion of first-in-class approvals has increased steadily each year since 1994, with the exception of the years 2005–2008, when the proportion was relatively high.

Slide8:

Related Reports Success Case Study: Green Giant "Swap-In" Frozen Vegetables - Frozen vegetable innovation making healthy swaps easier Innovation and Clinical Trial Tracking Factbook 2017: An Assessment of the Pharmaceutical Pipeline Frontier Pharma: First-in-Class Innovation in Hematological Cancers - Cytokine Signaling and Kinase Targeted Immunotherapies Dominate a Large and Highly Versatile Pipeline

Slide9:

CONTACT US We would be pleased to hear from you. Here you can find all important contacts. India, Maharashtra, Navi Mumbai. support@jsbmarketresearch.com www.jsbmarketresearch.com

Slide10:

Thank You JSB Market Research is developing new possibilities.

authorStream Live Help